vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($48.6M vs $24.8M, roughly 2.0× Ceribell, Inc.). Ouster, Inc. runs the higher net margin — 8.2% vs -54.6%, a 62.8% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
CBLL vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $48.6M |
| Net Profit | $-13.5M | $4.0M |
| Gross Margin | 87.3% | 42.9% |
| Operating Margin | -58.9% | 17.6% |
| Net Margin | -54.6% | 8.2% |
| Revenue YoY | — | 48.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.35 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $48.6M | ||
| Q4 25 | $24.8M | $62.2M | ||
| Q3 25 | $22.6M | $39.5M | ||
| Q2 25 | $21.2M | $35.0M | ||
| Q1 25 | $20.5M | $32.6M | ||
| Q4 24 | — | $30.1M | ||
| Q3 24 | $17.2M | $28.1M | ||
| Q2 24 | — | $27.0M |
| Q1 26 | — | $4.0M | ||
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $-21.7M | ||
| Q2 25 | $-13.6M | $-20.6M | ||
| Q1 25 | $-12.8M | $-22.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.4M | $-25.6M | ||
| Q2 24 | — | $-23.9M |
| Q1 26 | — | 42.9% | ||
| Q4 25 | 87.3% | 60.2% | ||
| Q3 25 | 88.3% | 42.1% | ||
| Q2 25 | 88.1% | 45.2% | ||
| Q1 25 | 87.9% | 41.3% | ||
| Q4 24 | — | 43.8% | ||
| Q3 24 | 87.3% | 38.3% | ||
| Q2 24 | — | 33.7% |
| Q1 26 | — | 17.6% | ||
| Q4 25 | -58.9% | 1.5% | ||
| Q3 25 | -64.8% | -61.4% | ||
| Q2 25 | -70.5% | -76.5% | ||
| Q1 25 | -69.3% | -73.0% | ||
| Q4 24 | — | -85.1% | ||
| Q3 24 | -57.8% | -98.0% | ||
| Q2 24 | — | -93.6% |
| Q1 26 | — | 8.2% | ||
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | -55.0% | ||
| Q2 25 | -64.4% | -58.8% | ||
| Q1 25 | -62.4% | -67.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -60.6% | -91.1% | ||
| Q2 24 | — | -88.4% |
| Q1 26 | — | $0.06 | ||
| Q4 25 | $-0.35 | $0.10 | ||
| Q3 25 | $-0.37 | $-0.37 | ||
| Q2 25 | $-0.38 | $-0.38 | ||
| Q1 25 | $-0.36 | $-0.42 | ||
| Q4 24 | — | $-0.46 | ||
| Q3 24 | $-1.85 | $-0.54 | ||
| Q2 24 | — | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $173.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $275.6M |
| Total Assets | $195.8M | $381.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $173.1M | ||
| Q4 25 | $159.3M | $208.6M | ||
| Q3 25 | $168.5M | $244.5M | ||
| Q2 25 | $177.4M | $226.5M | ||
| Q1 25 | $182.7M | $168.2M | ||
| Q4 24 | — | $172.0M | ||
| Q3 24 | $14.1M | $151.4M | ||
| Q2 24 | — | $184.2M |
| Q1 26 | — | $275.6M | ||
| Q4 25 | $155.3M | $261.7M | ||
| Q3 25 | $164.1M | $247.4M | ||
| Q2 25 | $172.2M | $221.0M | ||
| Q1 25 | $180.9M | $167.9M | ||
| Q4 24 | — | $180.9M | ||
| Q3 24 | $-136.0M | $171.7M | ||
| Q2 24 | — | $170.6M |
| Q1 26 | — | $381.5M | ||
| Q4 25 | $195.8M | $349.5M | ||
| Q3 25 | $199.5M | $353.8M | ||
| Q2 25 | $207.7M | $321.8M | ||
| Q1 25 | $213.5M | $268.6M | ||
| Q4 24 | — | $276.1M | ||
| Q3 24 | $47.1M | $255.2M | ||
| Q2 24 | — | $309.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | — |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.8M | $-15.4M | ||
| Q3 25 | $-11.1M | $-18.3M | ||
| Q2 25 | $-7.5M | $-1.3M | ||
| Q1 25 | $-11.4M | $-4.9M | ||
| Q4 24 | — | $-2.6M | ||
| Q3 24 | — | $-3.8M | ||
| Q2 24 | — | $-21.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-11.0M | $-37.2M | ||
| Q3 25 | $-11.5M | $-20.0M | ||
| Q2 25 | $-7.6M | $-2.2M | ||
| Q1 25 | $-11.6M | $-5.4M | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $-4.3M | ||
| Q2 24 | — | $-22.0M |
| Q1 26 | — | — | ||
| Q4 25 | -44.2% | -59.8% | ||
| Q3 25 | -50.8% | -50.7% | ||
| Q2 25 | -35.9% | -6.3% | ||
| Q1 25 | -56.4% | -16.6% | ||
| Q4 24 | — | -13.3% | ||
| Q3 24 | — | -15.4% | ||
| Q2 24 | — | -81.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 35.0% | ||
| Q3 25 | 1.6% | 4.3% | ||
| Q2 25 | 0.3% | 2.5% | ||
| Q1 25 | 0.7% | 1.7% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 1.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
OUST
| Product revenue | $48.2M | 99% |
| Royalties | $347.0K | 1% |
